Delivery Order SPE2DB20D3303-SPE2DB25FA3SE
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TRIUMEQ 600-50-300 MG tablets (30-count units) with a ceiling value of $78,899.37. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $6,519.84 for TRIUMEQ 600-50-300 mg tablets in quantities of 30, with a firm fixed price contract type. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in units of 30, with a ceiling value of $8,765.93. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...
- The Defense Logistics Agency awarded a $85,522.33 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This delivery order, valued at $7,559.40 with a firm fixed price structure, represents a competitive award with no set-aside designation. The contract is scheduled for ultimate completion on June 3, 2025, with performance based at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This contract, valued at $39,484.25, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The delivery order is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) valued at $6,519.84 under a Firm Fixed Price contract type. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and serves as a critical pharmaceutical distributor for...
- This delivery order, valued at $15,313.29 with an ultimate completion date of April 29, 2025, awards AmerisourceBergen Drug Corp the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. The Defense Logistics Agency (DLA), through its Medical Supply Chain, issued this firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the place of performance for this award—serves as a critical...
- This delivery order, awarded August 12, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 30-count supplies of TRIUMEQ 600-50-300 mg tablets with a ceiling value of $55,079.80 under firm fixed-price terms. The award, which carries an ultimate completion date of August 13, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $4,166.96 and an ultimate completion date of August 1, 2025. The contract does not utilize a set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3SEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This order, valued at $8,903.19, is issued under a firm fixed-price delivery order contract with an ultimate completion date of September 16, 2025. The award represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, providing a comprehensive range of pharmaceutical products and medical supplies to support federal medical procurement needs. This delivery order is executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains, with the flexibility to serve customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 9/15/25 |